ANDHealth, Australia’s first industry-led national accelerator for digital health technologies, has announced the six companies that will participate in its first cohort to benefit from a hands-on advisory group, drawn from a field of 55 applicants.
The unique ANDHealth model is led by a consortium of industry leaders, each with a proven track record in commercialising digital health technologies in global markets and supported by Australian Industry Growth Centre, MTPConnect.
The accelerator is focused on mid-stage technologies that will benefit from support and assistance in clinical and commercial validation to enhance their ability to penetrate global markets and/ or raise significant growth capital
ANDHealth’s industry members, which include AusBiotech, Novartis Pharmaceuticals, RMIT University, Planet Innovation, Curve Tomorrow, The Murdoch Children’s Research Institute, GP2U, HPM Executive and HealthXL, will work alongside each company to define and support a project that makes a significant contribution to their market readiness. I
In addition to the time and resources of the advisors, companies also can access $60k of project funds, media and communications training, intellectual property advice and access to a global network of digital health experts.
“We were genuinely overwhelmed by the number and quality of applications, given our focus is on companies that are already well down the product development pathway,” said ANDHealth Managing Director, Bronwyn Le Grice.
“The exceptional quality of the first cohort of companies is a clear indication of the global potential of our digital health sector and we are delighted to be working with such innovative and dynamic teams.”
The first cohort of companies includes the following companies:
DoseMe – A precision medicine dosing platform which improves dosing accuracy and patient outcomes through real-time medication dosing decision support.
Human Gas Capsule – A connected electronic pill sensor which provides real time gas information for gut health diagnosis and management.
Perx – A digital intervention for changing the way people and healthcare organisations approach medication adherence which forms positive habits through fun games and memorable rewards.
Seer Medical – A wearable device and cloud computing technology which delivers hospital standard epilepsy monitoring and diagnosis in the home.
SkinView –A point of care solution for diagnosis of skin cancer and skin lesions which transforms a smartphone into a diagnostic dermatoscope.
Highly Commended – PenPal – A digital allergy tool which empowers temporary carers of children with allergies through on the spot access to life saving personalised information and treatment steps.